$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

한국 성인에서 분리한 유산균의 VISA(Vancomycin-Intermediate Resistant Staphylococcus aureus)와 VRE(Vancomycin Resistant Enterococcus faecium)에 대한 성장 억제

Lactic Acid Bacteria Isolated from Healthy Korean Having Antimicrobial Activity Against VISA and VRE

약학회지 = Yakhak hoeji v.50 no.2 , 2006년, pp.78 - 83  
Abstract

VISA and VRE are the main causes of surgical infection, urinary tract infections and bacteremia in hospitals. In this study; we selected VISA (Vancomycin Intermediate resistant Staphylococcus aureus) and VRE (Vancomycin Resistant Enterococcus) isolated from the clinical isolates. One of the isolated strains indicated the high resistance to severel anti-biotics (Vancomycin, Teicoplanin, Mupirocin, Synercid, Ciprofloxacin, Gentamicin, Lincomycin, Cefotaxim, Meropenem). Antimicrobial activity of Bifidobacterium spp. against VISA and VRE were measured. About $10^4$ cells of VISA or VRE were mixed with 1,5 and 9 ml of Bifidobacterium and the final volume was adjusted to 10 ml with brain heart infusion (BHI) broth. The cell suspension was incubated for 3, 6, 9, and 24 hr, serially diluted and then plated on BHI agar plate. As numbers of Bifidobacterium were increased viable cell count of VISA and VRE decreased. The strongest antimicrobial activity of the Bifidobacterium was observed after 9hr incubation in any mixture, almost completely inhibiting the growth of VISA and VRE.

참고문헌 (23)

  1. Kwon, N. H., Kim, S. H., Bae, W. K., Kim, J. Y., Lim, J. Y., Noh, K. M., Kim, J. M., Ahn, J. S. and Park, Y. H. : Antimicrobial activity of Lactobacillus reuteri against major food-borne pathogens. J. Fd Hyg. Safety 16, 264 (2001) 
  2. Molder, H. W., Mckeller, R. C. and Yaguchi, M. : Bifidogenic factors-sources, meta-bolism and applications. Int. Dairy J. 4, 383 (1994) 
  3. Kim, J. B., Kim, G. H., Song, H. W., Park, S. U., Eom, Y. B., Park, S. W., Kim, Y. S. and Park, S. J. : Rapid detection of vancomycin resistant Enterococci using multiplex polymerase chain reactions. Korean J. Biome. Lab. Sci. 5, 95 (1999) 
  4. Olsen, S. J., Bishop, R., Brenner, F. W., Roels, T. H., Bean, N., Tauxe, R. V. and Slutsker, L. : The chainging epidemiology of Salmonella; trends in serotypes isolated from humans in the United State 1987-1997. J. Infect. Dis. 183, 753 (2002) 
  5. Uttley, A. H., Collins, C. H., Naidoo, J. and George, J. C. : Vancomycin-resistant enterococci. Lancet 1, 57 (1988) 
  6. Hsueh, P. R., Chen, W. H., Teng, L. J. and Luh, K. T. : Nosocomial infections due to methcillin-resistant Staphylococcus aureus and vamcomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003 : resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int. J. Antimicrob. Agents 26, 43 (2005) 
  7. Humphreys, H., Dolan, V., Sexton, T., Conlon, P., Rajan, L., Creamer, E., Walshe, J., Donohoe, J. and Symyth, E. G. : Implications of colonization of vancomycin-resistant enterococci (VRE) in renal dialysis patients. Learning to live with it- J. Hospital Infect. 58, 28 (2004) 
  8. Nelason, R. R. S., McGregor, K. F., Brown, A. R., Amyes, S. G. B. and Young, H. K. : Isolation and characterization of glycopeptide-resistant Enterococci from hospitalised patients over a 30-month period. J. Chin. Microbiol. 38, 2112 (2000) 
  9. Yoshida, O., Yasukata, T., Sumino, Y., Munekage, T., Narukawa, Y. and Nishitani, Y. : Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B. Bioorganic & Medicinal Chemistry Letters 12, 3037 (2002) 
  10. LeClercq, R., Perlot, E., Duval, J. and Courvalin, P. : Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319, 157 (1988) 
  11. Still, J., Law, E., Friedman, B., Fuhrman, S. and Newton, T. : Vancomycin-resistant organisms on a burn unit. South Med. J. 94, 810 (2001) 
  12. Wiston, L. G., Charlebois, E. D., Pang, S., Bangsberg, D. R., Perdreau-Remington, F. and Chambers III, H. F. : Impact of a formulary switch from ticarcillin-clavulanate to piperacillintazobacttam on colonization with vancomycin-resistant enterococci. American J. Infect. Control 32(8), 462 (2004) 
  13. Denis, O., Nonhoff, C., Byl, B., Knoop, C., Bobin-Dubreux, S. and Struelens, M. J. : Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital : microbiological and clinical features. J. Antimicrob. Chemotherapy 50, 383 (2002) 
  14. Dobbin, G., Hariharan, H., Daoust, P. Y., Hariharan, S., Heaney, S., Coles, M., Price, L. and Muckle, C. A. : Bacterial flora of free-living Double-crested cormorant (Phalacrocorax auritus) chicks on Prince Edward Island, Canada, with reference to enteric bacteria and antibiotic resistance. Comp. Immnu. Microbiol. & Infect. Dis. 28, 71 (2005) 
  15. Fridkin, S. K. : Vancomycin-intermediate and -resistant Staphylococcus aureus : What the infectious disease specialist needs to know. Clin. Infect. Dis. 32, 108 (2001) 
  16. Song, J. H. : Emerging infectious disease due to micorbial adaptation: Emergence and spread of antimicrobial resistance. Korean Society of Infection Disease, Infection and Chemotherapy 31, 79 (2002) 
  17. Kheadr, E., Bernoussi, N., Lacroix, C. and Fliss, I. : Compariasion of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. Int. Dairay J. 14, 1041 (2004) 
  18. Kim, S. H., Keon, N. H., Kim, J. Y., Lim, J. Y., Bae, W. K., Kim, J. M., Noh, H. J., Jung, W. K., Park, K. T., Lee, J. E., Ra, J. C. and Park, Y. H. : Antimicrobial activity of natural product made by opuntia ficus-indica var. saboten against Salmonella spp. and Escherichia coli O157:H7. J. Fd Hyg. 17, 71 (2002) 
  19. Bae, H. G., Kim, S. O., Parll, J. S., Kang, B. Y., Choi, S. S., Kang, C. Y. and Ha, N. J. : Analysis of Genomic diversity of Bifidobacterium spp. isolation from Korean adult. Yakhak Hoeji 48, 20 (2004) 
  20. Chun, U. H., Park, B. S. and Cho, J. S. : Optimum conditions for the protoplast formation of Lactobacillus plantarum and Lactobacillus plantarum. Korean J. Botechnol. Bioeng. 9, 191 (1994) 
  21. Lim, J. J. and Yun, H. I. : Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida. Int. J. Antimicrob. Agents 17, 471 (2001) 
  22. Yun, J. H., Yim, D. S., Kang, J. Y., Kang, B. Y., Shin, E. A., Chung, M. J., Kim, S. D., Baek, D. H., Choi, S. S. and Ha, N. J. : Identification of Lactobacillus ruminus SPM 0211 isolated from healthy Korean and screening for the antimicrobial activity of this strain against some pathogens. Arch. Pharm. Res. 28, 660 (2005) 
  23. Lee, K. M., Yun, J. H., Choi, S. S. and Ha, N. J. : Comparison of environmental growth condition in Bifidobacterium spp. parent and It's mutants. J. of Life Sci. 12, 113 (2004) 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

DOI 인용 스타일